Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$54.2 - $69.69 $173,440 - $223,008
3,200 New
3,200 $221,000
Q1 2021

May 14, 2021

SELL
$28.4 - $36.14 $286,840 - $365,014
-10,100 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$23.69 - $31.47 $239,269 - $317,847
10,100 New
10,100 $289,000
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $209,967 - $287,844
-5,100 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$52.95 - $71.34 $158,850 - $214,020
-3,000 Reduced 37.04%
5,100 $288,000
Q1 2018

May 15, 2018

BUY
$56.98 - $72.41 $461,538 - $586,521
8,100 New
8,100 $472,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $973M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.